• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昂丹司琼对类癌综合征胃肠道症状的影响。

Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome.

作者信息

Wymenga A N, de Vries E G, Leijsma M K, Kema I P, Kleibeuker J H

机构信息

Division of Medical Oncology, University Hospital, Groningen, The Netherlands.

出版信息

Eur J Cancer. 1998 Jul;34(8):1293-4. doi: 10.1016/s0959-8049(98)00009-4.

DOI:10.1016/s0959-8049(98)00009-4
PMID:9849494
Abstract

The effect of short-term treatment with the highly selective serotonin receptor antagonist ondansetron on symptoms and gastric emptying in 11 carcinoid patients was studied. Diarrhoea improved in 6 of 6 patients, nausea in 3 of 4 patients. Flushing was not affected. The rate of gastric emptying increased during ondansetron treatment (P = 0.08). No changes in serotonin in platelets and urinary excretion of 5-hydroxyindoleacetic acid were found. It is concluded that ondansetron can improve gastrointestinal symptoms in carcinoid patients and possibly slows gastric emptying.

摘要

研究了高选择性5-羟色胺受体拮抗剂恩丹西酮短期治疗对11例类癌患者症状及胃排空的影响。6例腹泻患者中有6例症状改善,4例恶心患者中有3例症状改善。面部潮红未受影响。恩丹西酮治疗期间胃排空率增加(P = 0.08)。未发现血小板中5-羟色胺及尿中5-羟吲哚乙酸排泄量有变化。结论是恩丹西酮可改善类癌患者的胃肠道症状,并可能减慢胃排空。

相似文献

1
Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome.昂丹司琼对类癌综合征胃肠道症状的影响。
Eur J Cancer. 1998 Jul;34(8):1293-4. doi: 10.1016/s0959-8049(98)00009-4.
2
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.奥氮平口服可有效治疗类癌综合征腹泻,且对生长抑素类似物无反应。
Oncologist. 2019 Feb;24(2):255-258. doi: 10.1634/theoncologist.2018-0191. Epub 2018 Aug 31.
3
Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.贾第虫感染后肠易激综合征和功能性消化不良中内脏敏感性增加。5-羟色胺3受体拮抗剂昂丹司琼的作用。
Neurogastroenterol Motil. 2007 Dec;19(12):977-82. doi: 10.1111/j.1365-2982.2007.00988.x. Epub 2007 Aug 17.
4
Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome.胃排空与恶心主观症状:5-羟色胺-3拮抗剂昂丹司琼对胃潴留综合征患者胃排空无影响
Digestion. 1990;46(2):89-96. doi: 10.1159/000200337.
5
Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.昂丹司琼。其药理学综述及新应用中的初步临床研究结果。
Drugs. 1996 Nov;52(5):773-94. doi: 10.2165/00003495-199652050-00010.
6
Ondansetron in carcinoid syndrome.昂丹司琼治疗类癌综合征。
Lancet. 1992 Jun 6;339(8806):1416. doi: 10.1016/0140-6736(92)91235-z.
7
Effect of the 5-HT3 receptor antagonist, ondansetron, on gastric size in dyspeptic patients with impaired gastric accommodation.5-羟色胺3(5-HT3)受体拮抗剂昂丹司琼对胃容纳功能受损的消化不良患者胃大小的影响。
Dig Liver Dis. 2008 Mar;40(3):188-93. doi: 10.1016/j.dld.2007.11.013. Epub 2008 Jan 31.
8
Treatment of diarrhea in carcinoid syndrome with ondansetron, tropisetron, and clonidine.使用昂丹司琼、托烷司琼和可乐定治疗类癌综合征中的腹泻。
Am J Gastroenterol. 1995 Apr;90(4):645-8.
9
A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea.5-羟色胺3拮抗剂可纠正类癌性腹泻患者的餐后结肠高渗反应。
Gastroenterology. 1994 May;106(5):1184-9. doi: 10.1016/0016-5085(94)90008-6.
10
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.替洛曲普明,一种新型血清素合成抑制剂,用于治疗类癌综合征和腹泻且奥曲肽控制效果不佳的患者。
Endocr Relat Cancer. 2014 Oct;21(5):705-14. doi: 10.1530/ERC-14-0173. Epub 2014 Jul 10.

引用本文的文献

1
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.类癌综合征是什么?对其拟议介质的批判性评估。
Endocr Rev. 2024 May 7;45(3):351-360. doi: 10.1210/endrev/bnad035.
2
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management.类癌综合征与神经内分泌肿瘤相关的高胰岛素血症性低血糖症:临床与药物治疗的批判性综述
Pharmaceuticals (Basel). 2021 Jun 4;14(6):539. doi: 10.3390/ph14060539.
3
Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome.
类癌综合征的病理生理学、治疗及并发症的最新进展
J Oncol. 2020 Jan 21;2020:8341426. doi: 10.1155/2020/8341426. eCollection 2020.
4
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.神经内分泌肿瘤的诊断和治疗进展。
Endocr Rev. 2020 Apr 1;41(2):371-403. doi: 10.1210/endrev/bnz004.
5
Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes.聚焦乙基曲罗司他治疗类癌综合征腹泻:患者选择及报告的结局
Cancer Manag Res. 2019 Aug 8;11:7537-7556. doi: 10.2147/CMAR.S181439. eCollection 2019.
6
Evidence-Based Policy in Practice: Management of Carcinoid Syndrome Diarrhea.实践中的循证政策:类癌综合征腹泻的管理
P T. 2019 Jul;44(7):424-427.
7
Nutritional and vitamin status in patients with neuroendocrine neoplasms.神经内分泌肿瘤患者的营养和维生素状况。
World J Gastroenterol. 2019 Mar 14;25(10):1171-1184. doi: 10.3748/wjg.v25.i10.1171.
8
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.奥氮平口服可有效治疗类癌综合征腹泻,且对生长抑素类似物无反应。
Oncologist. 2019 Feb;24(2):255-258. doi: 10.1634/theoncologist.2018-0191. Epub 2018 Aug 31.
9
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea.替洛利司他乙酯:一种用于治疗类癌综合征腹泻的新型药物。
Future Oncol. 2018 May;14(12):1155-1164. doi: 10.2217/fon-2017-0340. Epub 2018 Jan 19.
10
Management of the hormonal syndrome of neuroendocrine tumors.神经内分泌肿瘤激素综合征的管理
Arch Med Sci. 2017 Apr 1;13(3):515-524. doi: 10.5114/aoms.2016.60311. Epub 2016 Jun 1.